Vimarsana
Biggest News Aggregation in the World

Part Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Part Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Part Cells Today - Breaking & Trending Today

Unlocking the Fountain of Youth? New Research Suggests Reprogramming T Cells to Reverse Aging - Vimarsana News

Unlocking the Fountain of Youth? New Research Suggests Reprogramming T Cells to Reverse Aging

Researchers at Cold Spring Harbor Laboratory unveiled that T cells, a type of white blood cell, may hold the key to fighting aging and boosting the immune system.

'Be courageous and have the gut to invest': 1 oncology leader on collaboration and innovation - Vimarsana News

'Be courageous and have the gut to invest': 1 oncology leader on collaboration and innovation

Meet William Tse division director of hematology and oncology at MetroHealth in Cleveland. He has a passion for oncology and is focused on collaboration

Monitoring of T-cell invasions assay on a 3D spheroid model - Vimarsana News

Monitoring of T-cell invasions assay on a 3D spheroid model

Workflow for the generation of 3D tumor spheroids, co-cultured with T-cells as a proof-of-concept model for CAR T assays

Quantifying NK-mediated cytolysis of glioblastoma in vitro with Maestro Z - Vimarsana News

Quantifying NK-mediated cytolysis of glioblastoma in vitro with Maestro Z

Immunotherapies such as CAR T cells that have shown success in treating liquid tumors have had limited efficacy against solid tumors, including glioblastoma. Natural killer (NK) cells represent a promising approach for solid tumor treatment, and understanding mechanisms of NK-mediated cytotoxicity is important for cell therapy development. In this application note, Axion Biosystems quantifies the kinetics of both antibody-dependent cellular cytotoxicity (ADCC) and CAR NK-mediated cytolysis a

Chimeric Antigen Receptor CAR T Cells - Vimarsana News

Chimeric Antigen Receptor CAR T Cells

T cells engineered to express chimeric antigen receptors, commonly known as CAR T cells, have demonstrated the ability to help patients suffering from blood cancer.